Firefly Neuroscience (AIFF) vs Beamr Imaging (BMR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Firefly Neuroscience (AIFF) has outperformed Beamr Imaging (BMR) over the past year, losing 52.5% versus a loss of 61.2%. Firefly Neuroscience is the larger company by market cap ($11.8 million vs $11.6 million), about 1.0 times the size. Beamr Imaging converts more of its revenue into profit, with a net margin of -194.6% versus -1741.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIFF | BMR |
|---|---|---|
| Share price | $0.75 | $0.745 |
| Market cap | $11.81M | $11.57M |
| 1-day change | -9.64% | -13.18% |
| YTD return | -14.77% | -52.55% |
| 1-year return | -52.53% | -61.20% |
| 5-year return | -99.16% | — |
| EPS (TTM) | $-0.45 | $-0.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.14M | $3.09M |
| Revenue growth (YoY) | +957.41% | +0.98% |
| Net income (latest FY) | $-19.88M | $-6.02M |
| Gross margin | 56.48% | 89.72% |
| Operating margin | -775.48% | -208.60% |
| Net margin | -1740.98% | -194.57% |
| 52-week high | $3.15 | $2.51 |
| 52-week low | $0.62 | $0.74 |
| Distance from 52-week high | -76.19% | -70.32% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +571.14% |
| Average volume | 2.66M | 58.79K |
| Shares outstanding | 15.75M | 15.53M |
| Employees | 17 | 42 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Beamr Imaging is more profitable, keeping -194.6 cents of every revenue dollar as net income versus -1741.0 cents for Firefly Neuroscience.
- Firefly Neuroscience grew revenue faster in its latest fiscal year (+957.41% vs +0.98%).
About Firefly Neuroscience
AIFF stock →Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury.
Technology · Computer Software: Prepackaged Software · 17 employees
About Beamr Imaging
BMR stock →Beamr Imaging Ltd. engages in the content-adaptive video compression business in the United States, Israel, and internationally.
Technology · Computer Software: Prepackaged Software · 42 employees
AIFF vs BMR FAQ
Which is bigger, Firefly Neuroscience or Beamr Imaging?
Firefly Neuroscience (AIFF) is larger, with a market capitalization of $11.81M compared with $11.57M for Beamr Imaging (BMR).
Which stock has performed better over the past year, AIFF or BMR?
AIFF returned -52.53% over the past 12 months, compared with -61.20% for BMR (price return, excluding dividends). Past performance does not predict future results.
Are Firefly Neuroscience and Beamr Imaging in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.